Different effects of catechin on angiogenesis and inflammation depending on VEGF levels

Journal of Nutritional Biochemistry

Volumn 24, Issue 2, 2013, Pages 435-444

  Negrão, Rita ^a   Costa, Raquel ^a   Duarte, Delfim ^a   Gomes, Tiago Taveira ^a   Azevedo, Isabel ^a   Soares, Raquel ^a  

^a University of Porto   (Portugal)

Author keywords

Angiogenesis; Blood vessels; Catechin; Endothelial cells; Inflammation; Smooth muscle cells

Indexed keywords

CATECHIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIGEL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; SKIN INJURY; SMOOTH MUSCLE FIBER; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

ANIMALS; AORTA; APOPTOSIS; CATECHIN; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84872779241     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.12.011     Document Type: Article

References (43)

1. Chung A.S., Lee J., Ferrara N. Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer 2010, 10:505-514.
2. Ejaz S., Chekarova I., Ejaz A., Sohail A., Lim C.W. Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy. Diabetes Obes Metab 2008, 10:53-63.
3. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936.
4. Ferrara N., Kerbel R.S. Angiogenesis as a therapeutic target. Nature 2005, 438:967-974.
5. Folkman J. Is angiogenesis an organizing principle in biology and medicine?. J Pediatr Surg 2007, 42:1-11.
6. Oxidative stress, inflammation and angiogenesis in the metabolic syndrome 2009, 85-99. Springer Science, UK. R. Soares, C. Costa (Eds.).
7. Tammela T., Enholm B., Alitalo K., Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005, 65:550-563.
8. Fischer C., Mazzone M., Jonckx BCarmeliet P. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?. Nat Rev Cancer 2008, 8:942-956.
9. Bellomo D., Headrick J.P., Silins G.U., Paterson C.A., Thomas P.S., Gartside M., et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res 2000, 86:E29-E35.
10. Achen M.G., Jeltsch M., Kukk E., Makinen T., Vitali A., Wilks A.F., et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A 1998, 95:548-553.
11. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., et al. novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996, 15:290-298.
12. Tammela T., Zarkada G., Wallgard E., Murtomaki A., Suchting S., Wirzenius M., et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008, 454:656-660.
13. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-683.
14. Croll S.D., Ransohoff R.M., Cai N., Zhang Q., Martin F.J., Wei T., et al. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol 2004, 187:388-402.
15. Lichtenberger B.M., Tan P.K., Niederleithner H., Ferrara N., Petzelbauer P., Sibilia M. Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell 2010, 140:268-279.
16. Costa C., Incio J., Soares R. Angiogenesis and chronic inflammation: cause or consequence?. Angiogenesis 2007, 10:149-166.
17. Noonan D.M., De Lerma Barbaro A., Vannini N., Mortara L., Albini A. Inflammation, inflammatory cells and angiogenesis: decisions and indecisions. Cancer Metastasis Rev 2008, 27:31-40.
18. Rossi L., Mazzitelli S., Arciello M., Capo C.R., Rotilio G. Benefits from dietary polyphenols for brain aging and Alzheimer's disease. Neurochem Res 2008, 33:2390-2400.
19. Dell'Agli M., Busciala A., Bosisio E. Vascular effects of wine polyphenols. Cardiovasc Res 2004, 63:593-602.
20. Araujo J.R., Goncalves P., Martel F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr Res 2011, 31:77-87.
21. Monteiro R., Soares R., Guerreiro S., Pestana D., Calhau C., Azevedo I. Red wine increases adipose tissue aromatase expression and regulates body weight and adipocyte size. Nutrition 2009, 25:699-705.
22. Sabu M.C., Smitha K., Kuttan R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol 2002, 83:109-116.
23. Fraga C.G., Galleano M., Verstraeten S.V., Oteiza P.I. Basic biochemical mechanisms behind the health benefits of polyphenols. Mol Aspects Med 2010, 31:435-445.
24. Biesalski H.K. Polyphenols and inflammation: basic interactions. Curr Opin Clin Nutr Metab Care 2007, 10:724-728.
25. Kundu J.K., Surh Y.J. Epigallocatechin gallate inhibits phorbol ester-induced activation of NF-kappa B and CREB in mouse skin: role of p38 MAPK. Ann N Y Acad Sci 2007, 1095:504-512.
26. Chan M.M., Fong D., Ho C.T., Huang H.I. Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem Pharmacol 1997, 54:1281-1286.
27. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79:727-747.
28. Negrão R., Costa R., Duarte D., Taveira Gomes T., Mendanha M., Moura L., et al. Angiogenesis and inflammation signaling are targets of beer polyphenols on vascular cells. J Cell Biochem 2010, 111:1270-1279.
29. Soares R., Balogh G., Guo S., Gartner F., Russo J., Schmitt F. Evidence for the notch signaling pathway on the role of estrogen in angiogenesis. Mol Endocrinol 2004, 18:2333-2343.
30. Ruidavets J., Teissedre P., Ferrieres J., Carando S., Bougard G., Cabanis J. Catechin in the Mediterranean diet: vegetable, fruit or wine?. Atherosclerosis 2000, 153:107-117.
31. Kawai Y., Tanaka H., Murota K., Naito M., Terao J. (-)-Epicatechin gallate accumulates in foamy macrophages in human atherosclerotic aorta: implication in the anti-atherosclerotic actions of tea catechins. Biochem Biophys Res Commun 2008, 374:527-532.
32. Kajiya K., Kumazawa S., Nakayama T. Effects of external factors on the interaction of tea catechins with lipid bilayers. Biosci Biotechnol Biochem 2002, 66:2330-2335.
33. Sanae F., Miyaichi Y., Kizu H., Hayashi H. Effects of catechins on vascular tone in rat thoracic aorta with endothelium. Life Sci 2002, 71:2553-2562.
34. Maeda K., Kuzuya M., Cheng X.W., Asai T., Kanda S., Tamaya-Mori N., et al. Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. Atherosclerosis 2003, 166:23-30.
35. Lo H.M., Hung C.F., Huang Y.Y., Wu W.B. Tea polyphenols inhibit rat vascular smooth muscle cell adhesion and migration on collagen and laminin via interference with cell-ECM interaction. J Biomed Sci 2007, 14:637-645.
36. El Bedoui J., Oak M.H., Anglard P., Schini-Kerth V.B. Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression. Cardiovasc Res 2005, 67:317-325.
37. Auerbach R., Lewis R., Shinners B., Kubai L., Akhtar N. Angiogenesis assays: a critical overview. Clin Chem 2003, 49:32-40.
38. Guruvayoorappan C., Kuttan G. (+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-alpha in LPS-stimulated macrophages. Innate Immun 2008, 14:160-174.
39. Hamalainen M., Nieminen R., Vuorela P., Heinonen M., Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007, 2007:45673.
40. Kurbitz C., Heise D., Redmer T., Goumas F., Arlt A., Lemke J., et al. Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells. Cancer Sci 2011, 102:728-734.
41. Kim J.S., Kim J.M., JJ O., Jeon B.S. Inhibition of inducible nitric oxide synthase expression and cell death by (-)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J Clin Neurosci 2010, 17:1165-1168.
42. Lamy S., Blanchette M., Michaud-Levesque J., Lafleur R., Durocher Y., Moghrabi A., et al. Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation. Carcinogenesis 2006, 27:989-996.
43. Monteiro R., Calhau C., Silva A.O., Pinheiro-Silva S., Guerreiro S., Gartner F., et al. Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts. J Cell Biochem 2008, 104:1699-1707.